Last edition
News about Global Pharma
Palvella Therapeutics Secures US Patent for QTORIN Rapamycin
Palvella Therapeutics has secured its sixth US patent for QTORIN 3.9 percent rapamycin gel, strengthening intellectual property protection around its lead candidate for rare genetic skin diseases with no approved FDA therapies.
Global Pharma | 21/06/2025 | By Manvi | 155
FDA Clears Happy Ring as Class II Device for At-Home Sleep Disorder Diagnosis
Through the company's Happy Sleep platform, individuals order a sleep test online, wear the ring overnight, and review the results with a board-certified sleep physician – all in the comfort of their own home.
Global Pharma | 20/06/2025 | By Manvi | 391
Advanced Wellness Center Debuts Cutting-Edge Muscle Activation for Fat Loss and Recovery
Advanced Wellness Center is one of the first health centers in the area to offer leading-edge, noninvasive technology using muscle activation to build muscle, burn fat, help with muscle injury and recovery, and strengthen the pelvic floor.
Global Pharma | 20/06/2025 | By Manvi | 147
Pierre Fabre Laboratories has acquired global rights to two next-generation EGFR inhibitors – PFL-721 and PFL-241 – from Antares Therapeutics, strengthening its oncology pipeline with precision therapies targeting non-small cell lung cancer.
Global Pharma | 20/06/2025 | By Manvi | 222
Circle Pharma, a clinical-stage biotech firm developing macrocycle therapeutics for hard-to-treat cancers, has received Orphan Drug Designation from the US FDA for its investigational drug CID-078 targeting small cell lung cancer.
Global Pharma | 20/06/2025 | By Manvi | 131
Marksans Pharma’s UK subsidiary Relonchem has received MHRA approval for Oxybutynin hydrochloride 2.5mg/5ml Oral Solution, strengthening the company’s presence in the UK generics market across key therapeutic areas.
Global Pharma | 19/06/2025 | By Abha | 244
Miltenyi Biotec India, BIRAC Partner to Advance India's Cell and Gene Therapy Ecosystem
The partnership will focus on building local scientific capabilities, CAR-T clinical trials, addressing unmet medical needs and enhancing access through PoC manufacturing centres to strengthen India’s CGT capabilities.
Global Pharma | 19/06/2025 | By Abha | 353
Bayer Seeks US FDA Approval of gadoquatrane for MRI of CNS and Other Body Parts
Bayer has submitted a New Drug Application to the US FDA for gadoquatrane, an investigational MRI contrast agent. If approved, it would offer the lowest gadolinium dose among macrocyclic GBCAs in the US, cutting exposure by 60 percent while maintaining diagnostic efficacy.
Global Pharma | 18/06/2025 | By Abha | 265
BASF Opens New GMP Solution Centre in Michigan
BASF has inaugurated a state-of-the-art GMP Solution Center in Wyandotte, Michigan, reinforcing its commitment to innovation and quality in biopharma and pharmaceutical manufacturing through advanced, customer-centric solutions and rigorous quality standards.
Global Pharma | 18/06/2025 | By Abha | 164
AdventHealth Tampa First in Region to Perform Colorectal Surgery with da Vinci SP Robot
AdventHealth Tampa is now the first hospital in the Tampa Bay region to successfully perform a transabdominal colorectal surgery using the da Vinci SP (single port) robot, taking the next step forward in providing minimally invasive colorectal procedures.
Global Pharma | 17/06/2025 | By Manvi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy